Performance evaluation of the Roche Tina-quant Cystatin C assay and reference interval for cystatin C in healthy blood donors.
Erlandsen EJ, Randers E
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of biospecimen components, storage, and using serum rather than plasma on the measurements of cystatin C. Stability experiments were conducted on only 2 specimens, but 40 specimens were used to compare plasma and serum. 3 plasma specimens were spiked with hemoglobin, bilirubin, or intralipid to evaluate any interference with cystatin C measurement.
Summary of Findings
The authors report that there was no interference of hemoglobin, bilirubin or intralipid with the measurement of cystatin C in plasma, and cystatin C levels were stable in the two plasma specimens for at least 3 days at 20 degrees C, and 8 days at 4 degrees C. The levels of cystatin C were not significantly different between serum and lithium heparin plasma but were slightly lower when measured using the Roche kit rather than Siemen, particularly when cystatin C levels were high.
Biospecimens
FluidPlasmaFluidSerumPreservation Types
None (Fresh)Other PreservativeDiagnoses
NormalOther diagnosesPlatforms
ProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Reduced kidney functionBiospecimen Aliquots and Components Biospecimen components 20 g/L Intralipid<0.9 mmol/L Hemoglobin<353 umol/L bilirubinNormal plasmaBiospecimen Aliquots and Components Blood and blood products PlasmaSerumBiospecimen Preservation Type of fixation/preservation None (fresh)RefrigerationStorage Storage duration 0 days3 days8 daysStorage Storage temperature 20 degrees C4 degrees CClinical chemistry/auto analyzer Specific Technology platform RocheSiemens